MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 263 filers reported holding MIRATI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $371,000 | -23.2% | 4,515 | +31.3% | 0.06% | +113.3% |
| Q4 2021 | $483,000 | -27.1% | 3,439 | -16.2% | 0.03% | -74.1% |
| Q2 2021 | $663,000 | -39.1% | 4,105 | -35.4% | 0.12% | -19.4% |
| Q1 2021 | $1,088,000 | +10.3% | 6,353 | +41.5% | 0.14% | +11.6% |
| Q4 2020 | $986,000 | -4.6% | 4,491 | -27.9% | 0.13% | -2.3% |
| Q3 2020 | $1,034,000 | +334.5% | 6,229 | +237.6% | 0.13% | +238.5% |
| Q4 2019 | $238,000 | – | 1,845 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |